- Overview
- Product in Development
- Chemistry Skill
- Quality Control
- Manufacturing Facilities
- • Masulkhana
- • Parwanoo
- • Baddi
Home > Research & Development > Product in Development
Product in Development
Intermediates under Development :-
| S. No. | Product Name | Stage | CAS No. | Chemical Name |
| 1 | Aliskiren | ALN01 | Not Available | 4-Bromo-1-methoxy-2(3-methoxypropoxy) benzene |
| ALN07 | Not Available | (2S,7S)-2-isopropyl-7-{4-methoxy-3-(3-methoxypropoxy)bezyl}-8-methylnonayl-N,N-dimethylformamide | ||
| ALN08 | Not Available | (S)-2-[(S)-2-bromo-2-((2R,4S)-4-isopropyl-5-oxo- tetrahydrofuran-2-yl)-ethyl-1-[3-(3-methoxy propoxy)-4-methylphenyl] -3-methylbutyl ester | ||
| ALN10 | Not Available | (2S,4S,5S,7S)-5-azido-4-hydroxy-2-isopropy-7-[4-methoxypropoxy)-benzyl]-8-methyl nonanic acid (2-carbamoyl-2-methyl propyl) amide | ||
| AL10 | Not Available | 2(S)-(tert-butoxycarbonyl)amino-4(S)-isopropyl-5-(p-tert-butyl-phenyl)-pentanal. | ||
| 2 | Ezetimibe | EB02 | Not Available | (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxy pentanoyl]-4-phenyl-1,3- oxazolidin-2-one |
| EB03 | Not Available | (S)-3-{(R)-2-[(S)-4-(trimethylsilyloxy)-phenyl]-(4-fluorophenylamine)-methyl -4-[2-(4-fluorophenyl)-(1S)-trimethylsilyloxy]-butyric}-4-phenyl-oxazolidine-2-one | ||
| EB04 | Not Available | (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3- | ||
| (4-fluorophenyl)-3-(trimethylsilyloxy) propyl]-4-(4-(trimethylsilyloxy)phenyl)-2-azetidinone | ||||
| EZ04 | Not Available | (3R,4S)-1-(4-Fluorophenyl)-3-[3-(hydroxy)-3-oxopropyl]-4-(4-benzyloxyphenyl)-2-azetidonone | ||
| 3 | Eletriptan | EL06 | Not Available | 5-[2-(Benzene sulfonyl)ethenyl]-3-(1-methyl pyrrolidin-2(R)yl methyl)-1H-indole |
| 4 | Linezolid | LZN04 | Not Available | (5R)-5-(chloromethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone |
| LZN05 | Not Available | (S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]pthalamide | ||
| 5 | Quetiapine | QTS01 | 13349-82-1 | 1-[2-(2-Hydroxyethoxy) ethyl]piperazine |
| 6 | Valsartan | -- | 195435-23-5 | (R)-3-Methyl-2-(N-((2`-(2-trityl -2H-tetrazol-5-yl)biphenyl-4-yl) methyl)pentananamido) butanoic acid |
| OR Tritylvalsartan | ||||
| -- | 137863-20-8 | N-[2`-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-valine benzyl ester OR Valsartan benzyl ester | ||
| 7 | Ziprasidone | Int -I | 118289-55-7 | 5-(2-chloroethyl)-6-chlorooxindole |
| Int - II | 144010-02-6 | 3-(1-Piperazinyl)-1,2- benzisothiazole hydrochloride |
Note: The above intermediates are not for sales where the Patents are applicable & still valid.